Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Recurrence Score® on Recommendations for Adjuvant Treatment in Patients With ER-positive Breast Cancer

NCT01926964 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT01926964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01926964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Recurrence Score® on Recommendations for Adjuvant Treatment in Patients With ER-positive Breast Cancer
Lead sponsor
Swiss Cancer Institute
Phase
Observational
Overall status
Completed
Start date
September 30, 2013
Completion date
February 28, 2015
Enrollment
229 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer